Other Viruses Citation List: June 7 - June 20, 2013
Hepatitis B Virus
1. Non-competitive Inhibition of Hepatitis B Virus Reverse Transcriptase Priming and DNA Synthesis by the Nucleoside Analog Clevudine. Jones, S.A., E. Murakami, W. Delaney, P. Furman, and J. Hu. Antimicrobial Agents and Chemotherapy, 2013. [Epub ahead of print]; PMID[23774432].
[PubMed] OV_0607-062013.
2. Three New Secoiridoids, Swermacrolactones A-C and anti-Hepatitis B from Swertia macrosperma. Wang, H.L., C.A. Geng, Y.B. Ma, X.M. Zhang, and J.J. Chen. Fitoterapia, 2013. [Epub ahead of print]; PMID[23756190].
[PubMed] OV_0607-062013.
3. Engineered External Guide Sequences Are Highly Effective in Inhibiting Gene Expression and Replication of Hepatitis B Virus in Cultured Cells. Zhang, Z., G.P. Vu, H. Gong, C. Xia, Y.C. Chen, F. Liu, J. Wu, and S. Lu. Plos One, 2013. 8(6): p. e65268; PMID[23776459].
[PubMed] OV_0607-062013.
Hepatitis C Virus
4. Stapled Peptide-based Membrane Fusion Inhibitors of Hepatitis C Virus. Cui, H.K., J. Qing, Y. Guo, Y.J. Wang, L.J. Cui, T.H. He, L. Zhang, and L. Liu. Bioorganic & Medicinal Chemistry, 2013. 21(12): p. 3547-3554; PMID[23490158].
[PubMed] OV_0607-062013.
5. Discovery of Pyrido[2,3-d]pyrimidine-based Inhibitors of HCV NS5A. Degoey, D.A., D.A. Betebenner, D.J. Grampovnik, D. Liu, J.K. Pratt, M.D. Tufano, W. He, P. Krishnan, T.J. Pilot-Matias, K.C. Marsh, A. Molla, D.J. Kempf, and C.J. Maring. Bioorganic & Medicinal Chemistry Letters, 2013. 23(12): p. 3627-3630; PMID[23642966].
[PubMed] OV_0607-062013.
Human Cytomegalovirus
6. The Unique and Highly-selective Anti-cytomegalovirus Activities of Artemisinin-derived Dimer Diphenyl phosphate Stem from Combination of Dimer Unit and a Diphenyl phosphate Moiety. He, R., M. Forman, B.T. Mott, R. Venkatadri, G.H. Posner, and R. Arav-Boger. Antimicrobial Agents and Chemotherapy, 2013. [Epub ahead of print]; PMID[23774439].
[PubMed] OV_0607-062013.
7. Design, Synthesis, and Evaluation of WC5 Analogues as Inhibitors of Cytomegalovirus Immediate-early 2 Protein, a Promising Target for anti-HCMV Treatment. Massari, S., B. Mercorelli, L. Sancineto, S. Sabatini, V. Cecchetti, G. Gribaudo, G. Palu, C. Pannecouque, A. Loregian, and O. Tabarrini. ChemMedChem, 2013. [Epub ahead of print]; PMID[23757191].
[PubMed] OV_0607-062013.
HSV-2
8. Purification and Characterization of a Novel anti-HSV-2 Protein with Antiproliferative and Peroxidase Activities from Stellaria media. Shan, Y., Y. Zheng, F. Guan, J. Zhou, H. Zhao, B. Xia, and X. Feng. Acta Biochimica et Biophysica Sinica, 2013. [Epub ahead of print]; PMID[23761431].
[PubMed] OV_0607-062013.
Citations from the ISI Web of Knowledge Listings for O.V.
9. Screening and Identification of Compounds with Antiviral Activity against Hepatitis B Virus Using a Safe Compound Library and Novel Real-time Immune-absorbance PCR-based High Throughput System. Lamontagne, J., C. Mills, R.C. Mao, C. Goddard, D.W. Cai, H.T. Guo, A. Cuconati, T. Block, and X.Y. Lu. Antiviral Research, 2013. 98(1): p. 19-26; ISI[000318466200004].
[WOS] OV_0607-062013.